Cocrystal Pharma, Inc. is a clinical-stage biotechnology company. Co. is engaged in discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses (HCV). It is developing small molecule antiviral therapeutics that inhibit the essential viral replication function of RNA viruses causing acute and chronic viral diseases. It has several candidates under development for the treatment of influenza infection. CC-42344 is a novel PB2 inhibitor, which is a preclinical lead for the treatment of pandemic and seasonal influenza A. We show 35 historical shares outstanding datapoints in our COCP shares outstanding history coverage, used to compute COCP market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing COCP market cap history over the course of time is important for investors
interested in comparing COCP's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of COCP versus a peer is one thing; comparing
COCP market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like COCP can fluctuate over the course of history.
With this page we aim to empower investors researching COCP by allowing them to research the COCP market cap history. |
Free COCP Email Alerts:
Video: The Importance of Market Cap
